TreeWAS – Variant ID: rs2009501

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
K63.5 Polyp of colon	0.000	0.940	0.060
T39.1 4-Aminophenol derivatives	0.040	0.960	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.037	0.963	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.037	0.963	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.036	0.964	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.036	0.964	0.000
T43.6 Psychostimulants with abuse potential	0.034	0.966	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.034	0.966	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.033	0.967	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.032	0.967	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.032	0.968	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.032	0.968	0.000
I67.8 Other specified cerebrovascular diseases	0.000	0.969	0.031
T50.4 Drugs affecting uric acid metabolism	0.031	0.969	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.031	0.969	0.000
T50.1 Loop [high-ceiling] diuretics	0.029	0.971	0.000
T37.8 Other specified systemic anti-infectives and antiparasitics	0.029	0.971	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.029	0.971	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.028	0.972	0.000
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.027	0.972	0.000
T36 Poisoning by systemic antibiotics	0.027	0.973	0.000
T39.4 Antirheumatics, not elsewhere classified	0.027	0.973	0.000
T39.2 Pyrazolone derivatives	0.027	0.973	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.027	0.973	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.027	0.973	0.000
T43.9 Psychotropic drug, unspecified	0.026	0.974	0.000
T43.8 Other psychotropic drugs, not elsewhere classified	0.026	0.974	0.000
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.026	0.974	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.026	0.974	0.000
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.026	0.974	0.000
T50.7 Analeptics and opioid receptor antagonists	0.026	0.974	0.000
T50.5 Appetite depressants	0.026	0.974	0.000
T50.3 Electrolytic, caloric and water-balance agents	0.026	0.974	0.000
T50.0 Mineralocorticoids and their antagonists	0.026	0.974	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.026	0.974	0.000
T50.8 Diagnostic agents	0.025	0.975	0.000
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.025	0.975	0.000
T39.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.025	0.975	0.000
T44.7 Beta-Adrenoreceeptor antagonists, not elsewhere classified	0.025	0.975	0.000
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.025	0.975	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.025	0.975	0.000
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.024	0.975	0.000
T50.6 Antidotes and chelating agents, not elsewhere classified	0.024	0.976	0.000
T39.0 Salicylates	0.024	0.976	0.000
T38.8 Other and unspecified hormones and their synthetic substitutes	0.024	0.976	0.000
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.024	0.976	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.023	0.976	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.023	0.976	0.000
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.023	0.976	0.000
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.023	0.976	0.000
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.023	0.976	0.000
T44.1 Other parasympathomimetics [cholinergics]	0.023	0.976	0.000
T44.0 Anticholinesterase agents	0.023	0.976	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.023	0.976	0.000
T37.5 Antiviral drugs	0.023	0.976	0.000
T37.4 Anthelminthics	0.023	0.976	0.000
T37.3 Other antiprotozoal drugs	0.023	0.976	0.000
T37.2 Antimalarials and drugs acting on other blood protozoa	0.023	0.976	0.000
T37.1 Antimycobacterial drugs	0.023	0.976	0.000
T37.0 Sulphonamides	0.023	0.976	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.023	0.976	0.000
T48.5 Anti-common-cold drugs	0.023	0.977	0.000
T43.2 Other and unspecified antidepressants	0.023	0.977	0.000
T38.9 Other and unspecified hormone antagonists	0.022	0.978	0.000
T38.7 Androgens and anabolic congeners	0.022	0.978	0.000
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.022	0.978	0.000
T38.5 Other oestrogens and progestogens	0.022	0.978	0.000
T38.4 Oral contraceptives	0.022	0.978	0.000
T38.2 Antithyroid drugs	0.022	0.978	0.000
T38.0 Glucocorticoids and synthetic analogues	0.022	0.978	0.000
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.021	0.979	0.000
T48.4 Expectorants	0.021	0.979	0.000
T48.3 Antitussives	0.021	0.979	0.000
T48.2 Other and unspecified agents primarily acting on muscles	0.021	0.979	0.000
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.021	0.979	0.000
T48.0 Oxytocic drugs	0.021	0.979	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.021	0.979	0.000
T48.6 Antiasthmatics, not elsewhere classified	0.020	0.979	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.020	0.980	0.000
T42.0 Hydantoin derivatives	0.020	0.980	0.000
T36.0 Penicillins	0.020	0.980	0.000
T36.9 Systemic antibiotic, unspecified	0.019	0.980	0.000
T36.8 Other systemic antibiotics	0.019	0.980	0.000
T36.7 Antifungal antibiotics, systemically used	0.019	0.980	0.000
T36.6 Rifamycins	0.019	0.980	0.000
T36.5 Aminoglycosides	0.019	0.980	0.000
T36.4 Tetracyclines	0.019	0.980	0.000
T36.3 Macrolides	0.019	0.980	0.000
T36.2 Chloramphenicol group	0.019	0.980	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.019	0.980	0.000
T41.5 Therapeutic gases	0.019	0.980	0.000
T41.4 Anaesthetic, unspecified	0.019	0.980	0.000
T41.3 Local anaesthetics	0.019	0.980	0.000
T41.2 Other and unspecified general anaesthetics	0.019	0.980	0.000
T41.1 Intravenous anaesthetics	0.019	0.980	0.000
T41.0 Inhaled anaesthetics	0.019	0.980	0.000
T49.9 Topical agent, unspecified	0.019	0.980	0.000
T49.8 Other topical agents	0.019	0.980	0.000
T49.7 Dental drugs, topically applied	0.019	0.980	0.000
T49.6 Otorhinolaryngological drugs and preparations	0.019	0.980	0.000
T49.5 Ophthalmological drugs and preparations	0.019	0.980	0.000
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.019	0.980	0.000
T49.3 Emollients, demulcents and protectants	0.019	0.980	0.000
T49.2 Local astringents and local detergents	0.019	0.980	0.000
T49.1 Antipruritics	0.019	0.980	0.000
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.019	0.980	0.000
T42.3 Barbiturates	0.019	0.981	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.019	0.981	0.000
T42.2 Succinimides and oxazolidinediones	0.019	0.981	0.000
T38.1 Thyroid hormones and substitutes	0.019	0.981	0.000
T45.5 Anticoagulants	0.018	0.981	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.018	0.982	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.018	0.982	0.000
T45.0 Antiallergic and antiemetic drugs	0.017	0.983	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.017	0.983	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.017	0.983	0.000
T47.7 Emetics	0.017	0.983	0.000
T47.6 Antidiarrhoeal drugs	0.017	0.983	0.000
T47.5 Digestants	0.017	0.983	0.000
T47.4 Other laxatives	0.017	0.983	0.000
T47.3 Saline and osmotic laxatives	0.017	0.983	0.000
T47.0 Histamine H(2)-receptor antagonists	0.017	0.983	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.017	0.983	0.000
T45.8 Other primarily systemic and haematological agents	0.017	0.983	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.017	0.983	0.000
T45.6 Fibrinolysis-affecting drugs	0.017	0.983	0.000
T45.4 Iron and its compounds	0.017	0.983	0.000
T45.3 Enzymes, not elsewhere classified	0.017	0.983	0.000
T47.2 Stimulant laxatives	0.017	0.983	0.000
T45.2 Vitamins, not elsewhere classified	0.016	0.984	0.000
T40.5 Cocaine	0.016	0.984	0.000
T40.1 Heroin	0.016	0.984	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.015	0.985	0.000
T40.8 Lysergide [LSD]	0.015	0.985	0.000
T40.7 Cannabis (derivatives)	0.015	0.985	0.000
T40.3 Methadone	0.015	0.985	0.000
T40.0 Opium	0.015	0.985	0.000
T40.6 Other and unspecified narcotics	0.015	0.985	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.014	0.985	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.014	0.986	0.000
T42.1 Iminostilbenes	0.013	0.987	0.000
T40.4 Other synthetic narcotics	0.012	0.988	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.012	0.988	0.000
T42.4 Benzodiazepines	0.011	0.989	0.000
T40.2 Other opioids	0.011	0.989	0.000
T46.1 Calcium-channel blockers	0.011	0.989	0.000
D73.0 Hyposplenism	0.011	0.989	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.010	0.989	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.010	0.989	0.000
T46.7 Peripheral vasodilators	0.010	0.989	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.010	0.989	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.010	0.989	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.010	0.990	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.000	0.991	0.009
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.009	0.991	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.009	0.991	0.000
G44.2 Tension-type headache	0.008	0.992	0.000
D73 Diseases of spleen	0.007	0.993	0.000
C44.5 Skin of trunk	0.006	0.994	0.000
D73.8 Other diseases of spleen	0.006	0.994	0.000
I67 Other cerebrovascular diseases	0.000	0.994	0.006
T46.4 Angiotensin-converting-enzyme inhibitors	0.005	0.994	0.001
D73.9 Disease of spleen, unspecified	0.006	0.994	0.000
D73.1 Hypersplenism	0.006	0.994	0.000
G44 Other headache syndromes	0.006	0.994	0.000
D04.6 Skin of upper limb, including shoulder	0.005	0.995	0.000
M89.86 Other specified disorders of bone (Lower leg)	0.005	0.995	0.000
G44.0 Cluster headache syndrome	0.005	0.995	0.000
D73.5 Infarction of spleen	0.005	0.995	0.000
N85.4 Malposition of uterus	0.000	0.995	0.005
D73.2 Chronic congestive splenomegaly	0.005	0.995	0.000
G44.8 Other specified headache syndromes	0.005	0.995	0.000
M89.8 Other specified disorders of bone	0.005	0.995	0.000
I67.0 Dissection of cerebral arteries, nonruptured	0.000	0.995	0.005
M89.85 Other specified disorders of bone (Pelvic region and thigh)	0.005	0.995	0.000
D73.3 Abscess of spleen	0.005	0.995	0.000
D73.4 Cyst of spleen	0.005	0.995	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.000	0.995	0.005
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.000	0.995	0.005
I67.5 Moyamoya disease	0.000	0.995	0.005
I67.4 Hypertensive encephalopathy	0.000	0.995	0.005
I67.3 Progressive vascular leukoencephalopathy	0.000	0.995	0.005
J92.0 Pleural plaque with presence of asbestos	0.000	0.995	0.005
M89.88 Other specified disorders of bone (Other)	0.004	0.996	0.000
G44.1 Vascular headache, not elsewhere classified	0.004	0.996	0.000
I67.1 Cerebral aneurysm, nonruptured	0.000	0.996	0.004
S52.00 Fracture of upper end of ulna (closed)	0.000	0.996	0.004
G44.4 Drug-induced headache, not elsewhere classified	0.004	0.996	0.000
M89.84 Other specified disorders of bone (Hand)	0.004	0.996	0.000
M89.87 Other specified disorders of bone (Ankle and foot)	0.004	0.996	0.000
M13.00 Polyarthritis, unspecified (Multiple sites)	0.004	0.996	0.000
D04.5 Skin of trunk	0.004	0.996	0.000
Q82.5 Congenital nonneoplastic naevus	0.004	0.996	0.000
M89.82 Other specified disorders of bone (Upper arm)	0.004	0.996	0.000
M89.80 Other specified disorders of bone (Multiple sites)	0.004	0.996	0.000
M89.89 Other specified disorders of bone (Site unspecified)	0.004	0.996	0.000
M89.83 Other specified disorders of bone (Forearm)	0.004	0.996	0.000
M89.81 Other specified disorders of bone (Shoulder region)	0.004	0.996	0.000
G95.9 Disease of spinal cord, unspecified	0.004	0.996	0.000
E28.2 Polycystic ovarian syndrome	0.000	0.996	0.004
G44.3 Chronic posttraumatic headache	0.004	0.996	0.000
S52.01 Fracture of upper end of ulna (open)	0.000	0.996	0.004
S52.0 Fracture of upper end of ulna	0.000	0.996	0.004
D04 Carcinoma in situ of skin	0.004	0.996	0.000
D04.7 Skin of lower limb, including hip	0.003	0.997	0.000
J95.8 Other postprocedural respiratory disorders	0.000	0.997	0.003
R07.0 Pain in throat	0.003	0.997	0.000
H50.0 Convergent concomitant strabismus	0.003	0.997	0.000
D04.9 Skin, unspecified	0.003	0.997	0.000
Q82 Other congenital malformations of skin	0.003	0.997	0.000
H54.0 Blindness, both eyes	0.000	0.997	0.003
Z97.8 Presence of other specified devices	0.000	0.997	0.003
I67.9 Cerebrovascular disease, unspecified	0.000	0.997	0.003
B00.1 Herpesviral vesicular dermatitis	0.003	0.997	0.000
G12.2 Motor neuron disease	0.000	0.997	0.003
O36.0 Maternal care for rhesus isoimmunisation	0.003	0.997	0.000
S72.10 Pertrochanteric fracture (closed)	0.003	0.997	0.000
O26.9 Pregnancy-related condition, unspecified	0.003	0.997	0.000
I25.8 Other forms of chronic ischaemic heart disease	0.003	0.997	0.000
I25.2 Old myocardial infarction	0.003	0.997	0.000
Q87 Other specified congenital malformation syndromes affecting multiple systems	0.003	0.997	0.000
D04.8 Skin of other sites	0.003	0.997	0.000
D04.0 Skin of lip	0.003	0.997	0.000
M89 Other disorders of bone	0.003	0.997	0.000
Q87.4 Marfan's syndrome	0.003	0.997	0.000
Z04.3 Examination and observation following other accident	0.000	0.997	0.003
Q85 Phakomatoses, not elsewhere classified	0.003	0.997	0.000
Q80-Q89 Other congenital malformations	0.003	0.997	0.000
M89.96 Disorder of bone, unspecified (Lower leg)	0.003	0.997	0.000
B00.9 Herpesviral infection, unspecified	0.003	0.997	0.000
S52.10 Fracture of upper end of radius (closed)	0.000	0.997	0.003
F02.3 Dementia in Parkinson's disease	0.003	0.997	0.000
Q85.9 Phakomatosis, unspecified	0.003	0.997	0.000
Q82.2 Mastocytosis	0.003	0.997	0.000
F02 Dementia in other diseases classified elsewhere	0.003	0.997	0.000
I67.2 Cerebral atherosclerosis	0.000	0.997	0.003
B00 Herpesviral [herpes simplex] infections	0.003	0.997	0.000
M89.94 Disorder of bone, unspecified (Hand)	0.003	0.997	0.000
D04.4 Skin of scalp and neck	0.003	0.997	0.000
F03 Unspecified dementia	0.003	0.997	0.000
F00-F09 Organic, including symptomatic, mental disorders	0.003	0.997	0.000
K63 Other diseases of intestine	0.000	0.997	0.003
K63.8 Other specified diseases of intestine	0.000	0.997	0.003
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.003	0.997	0.000
F06.7 Mild cognitive disorder	0.003	0.997	0.000
F06 Other mental disorders due to brain damage and dysfunction and to physical disease	0.003	0.997	0.000
B00.4 Herpesviral encephalitis	0.003	0.997	0.000
Q87.2 Congenital malformation syndromes predominantly involving limbs	0.003	0.997	0.000
S52.1 Fracture of upper end of radius	0.000	0.997	0.003
F00 Dementia in Alzheimer's disease	0.003	0.997	0.000
Z87.7 Personal history of congenital malformations, deformations and chromosomal abnormalities	0.000	0.997	0.003
Q82.9 Congenital malformation of skin, unspecified	0.002	0.997	0.000
Q82.4 Ectodermal dysplasia (anhidrotic)	0.002	0.997	0.000
Q82.3 Incontinentia pigmenti	0.002	0.997	0.000
Q82.1 Xeroderma pigmentosum	0.002	0.997	0.000
Q85.1 Tuberous sclerosis	0.002	0.997	0.000
D04.1 Skin of eyelid, including canthus	0.002	0.997	0.000
Q87.0 Congenital malformation syndromes predominantly affecting facial appearance	0.002	0.997	0.000
Q83 Congenital malformations of breast	0.002	0.997	0.000
M89.5 Osteolysis	0.002	0.997	0.000
M89.0 Algoneurodystrophy	0.002	0.997	0.000
Q85.0 Neurofibromatosis (nonmalignant)	0.002	0.997	0.000
H20.9 Iridocyclitis, unspecified	0.000	0.997	0.002
M89.4 Other hypertrophic osteo-arthropathy	0.002	0.997	0.000
M89.9 Disorder of bone, unspecified	0.002	0.998	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.998	0.000
S52 Fracture of forearm	0.000	0.998	0.002
D04.2 Skin of ear and external auricular canal	0.002	0.998	0.000
Q82.0 Hereditary lymphoedema	0.002	0.998	0.000
Q87.5 Other congenital malformation syndromes with other skeletal changes	0.002	0.998	0.000
Q87.3 Congenital malformation syndromes involving early overgrowth	0.002	0.998	0.000
Q87.1 Congenital malformation syndromes predominantly associated with short stature	0.002	0.998	0.000
F00.1 Dementia in Alzheimer's disease with late onset	0.002	0.998	0.000
M89.6 Osteopathy after poliomyelitis	0.002	0.998	0.000
M89.2 Other disorders of bone development and growth	0.002	0.998	0.000
M89.1 Epiphyseal arrest	0.002	0.998	0.000
F07 Personality and behavioural disorders due to brain disease, damage and dysfunction	0.002	0.998	0.000
B00.3 Herpesviral meningitis	0.002	0.998	0.000
D26.9 Uterus, unspecified	0.000	0.998	0.002
Q89 Other congenital malformations, not elsewhere classified	0.002	0.998	0.000
Q86 Congenital malformation syndromes due to known exogenous causes, not elsewhere classified	0.002	0.998	0.000
Q84 Other congenital malformations of integument	0.002	0.998	0.000
Q81 Epidermolysis bullosa	0.002	0.998	0.000
Q80 Congenital ichthyosis	0.002	0.998	0.000
Q83.8 Other congenital malformations of breast	0.002	0.998	0.000
H18.6 Keratoconus	0.002	0.998	0.000
B00.8 Other forms of herpesviral infection	0.002	0.998	0.000
F02.8 Dementia in other specified diseases classified elsewhere	0.002	0.998	0.000
N99.2 Postprocedural adhesions of vagina	0.000	0.998	0.002
F02.0 Dementia in Pick's disease	0.002	0.998	0.000
F07.2 Postconcussional syndrome	0.002	0.998	0.000
S52.8 Fracture of other parts of forearm	0.000	0.998	0.002
F00.0 Dementia in Alzheimer's disease with early onset	0.002	0.998	0.000
F02.4 Dementia in human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
F02.2 Dementia in Huntington's disease	0.002	0.998	0.000
F02.1 Dementia in Creutzfeldt-Jakob disease	0.002	0.998	0.000
B00.7 Disseminated herpesviral disease	0.002	0.998	0.000
B00.0 Eczema herpeticum	0.002	0.998	0.000
F00.9 Dementia in Alzheimer's disease, unspecified	0.002	0.998	0.000
F01 Vascular dementia	0.002	0.998	0.000
D04.3 Skin of other and unspecified parts of face	0.002	0.998	0.000
F09 Unspecified organic or symptomatic mental disorder	0.002	0.998	0.000
F04 Organic amnesic syndrome, not induced by alcohol and other psychoactive substances	0.002	0.998	0.000
S52.7 Multiple fractures of forearm	0.000	0.998	0.002
N99.3 Prolapse of vaginal vault after hysterectomy	0.000	0.998	0.002
M89.06 Algoneurodystrophy (Lower leg)	0.002	0.998	0.000
H19.3 Keratitis and keratoconjunctivitis in other diseases classified elsewhere	0.002	0.998	0.000
H65.9 Nonsuppurative otitis media, unspecified	0.000	0.998	0.002
M89.55 Osteolysis (Pelvic region and thigh)	0.002	0.998	0.000
M89.90 Disorder of bone, unspecified (Multiple sites)	0.002	0.998	0.000
S52.80 Fracture of other parts of forearm (closed)	0.000	0.998	0.002
Q83.3 Accessory nipple	0.002	0.998	0.000
F06.8 Other specified mental disorders due to brain damage and dysfunction and to physical disease	0.002	0.998	0.000
F06.6 Organic emotionally labile [asthenic] disorder	0.002	0.998	0.000
F06.5 Organic dissociative disorder	0.002	0.998	0.000
F06.4 Organic anxiety disorder	0.002	0.998	0.000
F06.3 Organic mood [affective] disorders	0.002	0.998	0.000
F06.2 Organic delusional [schizophrenia-like] disorder	0.002	0.998	0.000
F06.1 Organic catatonic disorder	0.002	0.998	0.000
F06.0 Organic hallucinosis	0.002	0.998	0.000
K63.4 Enteroptosis	0.000	0.998	0.002
Q85.8 Other phakomatoses, not elsewhere classified	0.002	0.998	0.000
M89.40 Other hypertrophic osteoarthropathy (Multiple sites)	0.002	0.998	0.000
S52.11 Fracture of upper end of radius (open)	0.000	0.998	0.002
M89.07 Algoneurodystrophy (Ankle and foot)	0.002	0.998	0.000
S52.61 Fracture of lower end of both ulna and radius (open)	0.000	0.998	0.002
F06.9 Unspecified mental disorder due to brain damage and dysfunction and to physical disease	0.002	0.998	0.000
M13.0 Polyarthritis, unspecified	0.002	0.998	0.000
Q87.8 Other specified congenital malformation syndromes, not elsewhere classified	0.002	0.998	0.000
S52.3 Fracture of shaft of radius	0.000	0.998	0.002
I84.4 External haemorrhoids with other complications	0.002	0.998	0.000
M89.93 Disorder of bone, unspecified (Forearm)	0.002	0.998	0.000
K63.0 Abscess of intestine	0.000	0.998	0.002
Q83.9 Congenital malformation of breast, unspecified	0.002	0.998	0.000
Q83.2 Absent nipple	0.002	0.998	0.000
Q83.0 Congenital absence of breast with absent nipple	0.002	0.998	0.000
F05 Delirium, not induced by alcohol and other psychoactive substances	0.002	0.998	0.000
M89.08 Algoneurodystrophy (Other)	0.002	0.998	0.000
M89.05 Algoneurodystrophy (Pelvic region and thigh)	0.002	0.998	0.000
M89.02 Algoneurodystrophy (Upper arm)	0.002	0.998	0.000
M89.01 Algoneurodystrophy (Shoulder region)	0.002	0.998	0.000
M89.00 Algoneurodystrophy (Multiple sites)	0.002	0.998	0.000
M89.59 Osteolysis (Site unspecified)	0.002	0.998	0.000
M89.58 Osteolysis (Other)	0.002	0.998	0.000
M89.57 Osteolysis (Ankle and foot)	0.002	0.998	0.000
M89.56 Osteolysis (Lower leg)	0.002	0.998	0.000
M89.54 Osteolysis (Hand)	0.002	0.998	0.000
M89.53 Osteolysis (Forearm)	0.002	0.998	0.000
M89.52 Osteolysis (Upper arm)	0.002	0.998	0.000
M89.51 Osteolysis (Shoulder region)	0.002	0.998	0.000
M89.50 Osteolysis (Multiple sites)	0.002	0.998	0.000
S52.70 Multiple fractures of forearm (closed)	0.000	0.998	0.002
F05.1 Delirium superimposed on dementia	0.002	0.998	0.000
M89.49 Other hypertrophic osteoarthropathy (Site unspecified)	0.002	0.998	0.000
M89.48 Other hypertrophic osteoarthropathy (Other)	0.002	0.998	0.000
M89.47 Other hypertrophic osteoarthropathy (Ankle and foot)	0.002	0.998	0.000
M89.46 Other hypertrophic osteoarthropathy (Lower leg)	0.002	0.998	0.000
M89.45 Other hypertrophic osteoarthropathy (Pelvic region and thigh)	0.002	0.998	0.000
M89.44 Other hypertrophic osteoarthropathy (Hand)	0.002	0.998	0.000
M89.43 Other hypertrophic osteoarthropathy (Forearm)	0.002	0.998	0.000
M89.42 Other hypertrophic osteoarthropathy (Upper arm)	0.002	0.998	0.000
M89.41 Other hypertrophic osteoarthropathy (Shoulder region)	0.002	0.998	0.000
M89.04 Algoneurodystrophy (Hand)	0.002	0.998	0.000
M89.03 Algoneurodystrophy (Forearm)	0.002	0.998	0.000
M89.99 Disorder of bone, unspecified (Site unspecified)	0.002	0.998	0.000
H21.8 Other specified disorders of iris and ciliary body	0.002	0.998	0.000
F00.2 Dementia in Alzheimer's disease, atypical or mixed type	0.002	0.998	0.000
M89.3 Hypertrophy of bone	0.002	0.998	0.000
S52.9 Fracture of forearm, part unspecified	0.000	0.998	0.002
G60.8 Other hereditary and idiopathic neuropathies	0.002	0.998	0.000
N99.0 Postprocedural renal failure	0.000	0.998	0.002
M89.09 Algoneurodystrophy (Site unspecified)	0.002	0.998	0.000
N99.8 Other postprocedural disorders of genito-urinary system	0.000	0.998	0.002
M89.19 Epiphyseal arrest (Site unspecified)	0.002	0.998	0.000
M89.18 Epiphyseal arrest (Other)	0.002	0.998	0.000
M89.17 Epiphyseal arrest (Ankle and foot)	0.002	0.998	0.000
M89.16 Epiphyseal arrest (Lower leg)	0.002	0.998	0.000
M89.15 Epiphyseal arrest (Pelvic region and thigh)	0.002	0.998	0.000
M89.14 Epiphyseal arrest (Hand)	0.002	0.998	0.000
M89.13 Epiphyseal arrest (Forearm)	0.002	0.998	0.000
M89.12 Epiphyseal arrest (Upper arm)	0.002	0.998	0.000
M89.11 Epiphyseal arrest (Shoulder region)	0.002	0.998	0.000
M89.10 Epiphyseal arrest (Multiple sites)	0.002	0.998	0.000
M89.29 Other disorders of bone development and growth (Site unspecified)	0.002	0.998	0.000
M89.28 Other disorders of bone development and growth (Other)	0.002	0.998	0.000
M89.27 Other disorders of bone development and growth (Ankle and foot)	0.002	0.998	0.000
M89.26 Other disorders of bone development and growth (Lower leg)	0.002	0.998	0.000
M89.25 Other disorders of bone development and growth (Pelvic region and thigh)	0.002	0.998	0.000
M89.24 Other disorders of bone development and growth (Hand)	0.002	0.998	0.000
M89.23 Other disorders of bone development and growth (Forearm)	0.002	0.998	0.000
M89.22 Other disorders of bone development and growth (Upper arm)	0.002	0.998	0.000
M89.21 Other disorders of bone development and growth (Shoulder region)	0.002	0.998	0.000
M89.20 Other disorders of bone development and growth (Multiple sites)	0.002	0.998	0.000
M89.69 Osteopathy after poliomyelitis (Site unspecified)	0.002	0.998	0.000
M89.68 Osteopathy after poliomyelitis (Other)	0.002	0.998	0.000
M89.67 Osteopathy after poliomyelitis (Ankle and foot)	0.002	0.998	0.000
M89.66 Osteopathy after poliomyelitis (Lower leg)	0.002	0.998	0.000
M89.65 Osteopathy after poliomyelitis (Pelvic region and thigh)	0.002	0.998	0.000
M89.64 Osteopathy after poliomyelitis (Hand)	0.002	0.998	0.000
M89.63 Osteopathy after poliomyelitis (Forearm)	0.002	0.998	0.000
M89.62 Osteopathy after poliomyelitis (Upper arm)	0.002	0.998	0.000
M89.61 Osteopathy after poliomyelitis (Shoulder region)	0.002	0.998	0.000
M89.60 Osteopathy after poliomyelitis (Multiple sites)	0.002	0.998	0.000
M89.91 Disorder of bone, unspecified (Shoulder region)	0.002	0.998	0.000
F07.9 Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction	0.002	0.998	0.000
F07.8 Other organic personality and behavioural disorders due to brain disease, damage and dysfunction	0.002	0.998	0.000
F07.1 Postencephalitic syndrome	0.002	0.998	0.000
Q89.9 Congenital malformation, unspecified	0.002	0.998	0.000
Q89.8 Other specified congenital malformations	0.002	0.998	0.000
Q89.7 Multiple congenital malformations, not elsewhere classified	0.002	0.998	0.000
Q89.4 Conjoined twins	0.002	0.998	0.000
Q89.3 Situs inversus	0.002	0.998	0.000
Q89.1 Congenital malformations of adrenal gland	0.002	0.998	0.000
Q89.0 Congenital malformations of spleen	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.998	0.002
N99 Postprocedural disorders of genito-urinary system, not elsewhere classified	0.000	0.998	0.002
Q80.9 Congenital ichthyosis, unspecified	0.002	0.998	0.000
Q80.8 Other congenital ichthyosis	0.002	0.998	0.000
Q80.4 Harlequin foetus	0.002	0.998	0.000
Q80.3 Congenital bullous ichthyosiform erythroderma	0.002	0.998	0.000
Q80.2 Lamellar ichthyosis	0.002	0.998	0.000
Q80.1 X-linked ichthyosis	0.002	0.998	0.000
Q80.0 Ichthyosis vulgaris	0.002	0.998	0.000
Q81.9 Epidermolysis bullosa, unspecified	0.002	0.998	0.000
Q81.8 Other epidermolysis bullosa	0.002	0.998	0.000
Q81.2 Epidermolysis bullosa dystrophica	0.002	0.998	0.000
Q81.1 Epidermolysis bullosa letalis	0.002	0.998	0.000
Q81.0 Epidermolysis bullosa simplex	0.002	0.998	0.000
Q84.9 Congenital malformation of integument, unspecified	0.002	0.998	0.000
Q84.8 Other specified congenital malformations of integument	0.002	0.998	0.000
Q84.6 Other congenital malformations of nails	0.002	0.998	0.000
Q84.5 Enlarged and hypertrophic nails	0.002	0.998	0.000
Q84.4 Congenital leukonychia	0.002	0.998	0.000
Q84.3 Anonychia	0.002	0.998	0.000
Q84.2 Other congenital malformations of hair	0.002	0.998	0.000
Q84.1 Congenital morphological disturbances of hair, not elsewhere classified	0.002	0.998	0.000
Q84.0 Congenital alopecia	0.002	0.998	0.000
Q86.8 Other congenital malformation syndromes due to known exogenous causes	0.002	0.998	0.000
Q86.2 Dysmorphism due to warfarin	0.002	0.998	0.000
Q86.1 Foetal hydantoin syndrome	0.002	0.998	0.000
Q86.0 Foetal alcohol syndrome (dysmorphic)	0.002	0.998	0.000
S52.6 Fracture of lower end of both ulna and radius	0.000	0.998	0.002
B00.5 Herpesviral ocular disease	0.002	0.998	0.000
D26.1 Corpus uteri	0.000	0.998	0.002
Q82.8 Other specified congenital malformations of skin	0.002	0.998	0.000
Q89.2 Congenital malformations of other endocrine glands	0.002	0.998	0.000
H19 Disorders of sclera and cornea in diseases classified elsewhere	0.002	0.998	0.000
S52.81 Fracture of other parts of forearm (open)	0.000	0.998	0.002
S52.4 Fracture of shafts of both ulna and radius	0.000	0.998	0.002
C21.0 Anus, unspecified	0.000	0.998	0.002
F01.8 Other vascular dementia	0.002	0.998	0.000
F01.3 Mixed cortical and subcortical vascular dementia	0.002	0.998	0.000
F01.2 Subcortical vascular dementia	0.002	0.998	0.000
F01.0 Vascular dementia of acute onset	0.002	0.998	0.000
S52.30 Fracture of shaft of radius (closed)	0.000	0.998	0.002
S52.71 Multiple fractures of forearm (open)	0.000	0.998	0.002
F01.9 Vascular dementia, unspecified	0.002	0.998	0.000
F01.1 Multi-infarct dementia	0.002	0.998	0.000
M89.92 Disorder of bone, unspecified (Upper arm)	0.002	0.998	0.000
N99.5 Malfunction of external stoma of urinary tract	0.000	0.998	0.002
Q83.1 Accessory breast	0.002	0.998	0.000
S52.2 Fracture of shaft of ulna	0.000	0.998	0.002
M13.06 Polyarthritis, unspecified (Lower leg)	0.002	0.998	0.000
H19.2 Keratitis and keratoconjunctivitis in other infectious and parasitic diseases classified elsewhere	0.002	0.998	0.000
C18.6 Descending colon	0.000	0.998	0.002
M13.08 Polyarthritis, unspecified (Other)	0.002	0.998	0.000
M13.07 Polyarthritis, unspecified (Ankle and foot)	0.002	0.998	0.000
M13.05 Polyarthritis, unspecified (Pelvic region and thigh)	0.002	0.998	0.000
M13.04 Polyarthritis, unspecified (Hand)	0.002	0.998	0.000
M13.03 Polyarthritis, unspecified (Forearm)	0.002	0.998	0.000
M13.02 Polyarthritis, unspecified (Upper arm)	0.002	0.998	0.000
M13.01 Polyarthritis, unspecified (Shoulder region)	0.002	0.998	0.000
S52.31 Fracture of shaft of radius (open)	0.000	0.998	0.002
F05.0 Delirium not superimposed on dementia, so described	0.002	0.998	0.000
H18 Other disorders of cornea	0.002	0.998	0.000
M13.09 Polyarthritis, unspecified (Site unspecified)	0.002	0.998	0.000
F07.0 Organic personality disorder	0.002	0.998	0.000
H21 Other disorders of iris and ciliary body	0.002	0.998	0.000
M89.39 Hypertrophy of bone (Site unspecified)	0.001	0.998	0.000
M89.36 Hypertrophy of bone (Lower leg)	0.001	0.998	0.000
M89.35 Hypertrophy of bone (Pelvic region and thigh)	0.001	0.998	0.000
M89.34 Hypertrophy of bone (Hand)	0.001	0.998	0.000
M89.33 Hypertrophy of bone (Forearm)	0.001	0.998	0.000
M89.32 Hypertrophy of bone (Upper arm)	0.001	0.998	0.000
M89.31 Hypertrophy of bone (Shoulder region)	0.001	0.998	0.000
M89.30 Hypertrophy of bone (Multiple sites)	0.001	0.998	0.000
S52.91 Fracture of forearm, part unspecified (open)	0.000	0.998	0.002
S52.90 Fracture of forearm, part unspecified (closed)	0.000	0.998	0.002
H21.0 Hyphaema	0.002	0.998	0.000
J15.1 Pneumonia due to Pseudomonas	0.000	0.998	0.002
T02.40 Fractures involving multiple regions of both upper limbs (closed)	0.002	0.998	0.000
G12 Spinal muscular atrophy and related syndromes	0.000	0.998	0.002
H15.0 Scleritis	0.002	0.998	0.000
H18.4 Corneal degeneration	0.002	0.998	0.000
H19.8 Other disorders of sclera and cornea in diseases classified elsewhere	0.002	0.998	0.000
H19.0 Scleritis and episcleritis in diseases classified elsewhere	0.002	0.998	0.000
H15 Disorders of sclera	0.002	0.998	0.000
G60.0 Hereditary motor and sensory neuropathy	0.002	0.998	0.000
R16.0 Hepatomegaly, not elsewhere classified	0.000	0.998	0.002
H21.4 Pupillary membranes	0.002	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations